recombinant human erythropoietin therapy in critically ill patients a dose-response study [isrctn48523317]重组人红细胞生成素治疗危重病人剂量反应研究[isrctn48523317].pdfVIP

Available online /content/9/5/R508 Vol 9 No 5 Open Access Research Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCT 1 2 3 4 Dimitris Georgopoulos , Dimitris Matamis , Christina Routsi , Argiris Michalopoulos , 5 6 7 8 Nina Maggina , George Dimopoulos , Epaminondas Zakynthinos , George Nakos , 9 10 11 George Thomopoulos , Kostas Mandragos , Alice Maniatis and the Critical Care Clinical Trials Greek Group 1Professor of Medicine ICU Director, Department of Intensive Care Medicine, University Hospital of Heraklion, University of Crete, Heraklion, Crete, Greece 2ICU Director, Intensive Care Unit, Papageorgiou Hospital of Thessaloniki, Thessaloniki, Greece 3Assistant Professor of Medicine, Department of Intensive Care, Evangelismos Hospital, University of Athens, Athens, Greece 4ICU Director, Intensive Care Unit, Henry Dunan Hospital, Athens 5ICU Director, Intensive Care Unit, Saint Olga Hospital, Athens, Greece 6Intensive Care Unit, Sotiria Hospital, Athens, Greece 7Assistant Professor of Medicine ICU Director, Intensive Care Unit, University Hospital of Larisa, University of Larisa, Larisa, Greece 8Associate Professor of Medicine, Intensive Care Unit, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece 9ICU Director, Intensive Care Unit, Laiko Hospital, Athens 10ICU Director, Hellenic Red Cr